Cancer Research UK-funded scientists have made an unusual discovery that could help to identify patients who are up to two and a half times more likely to respond to currently available cancer drugs.
Medtronic Expands AI-Driven Partnership with Cosmo Pharmaceuticals
What You Should Know: – Medtronic announced an expanded AI partnership with Cosmo Pharmaceuticals NV, a pharmaceutical company, to further advance AI-powered solutions in the